Questions about NOD mouse diabetes

Research in Immunology

Volumn 148, Issue 5, 1997, Pages 286-291

  Cohen, I R ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; HLA ANTIGEN CLASS 2;

ADOPTIVE TRANSFER; ANTIGEN EXPRESSION; ANTIGEN SPECIFICITY; EXPERIMENTAL DIABETES MELLITUS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; INSULIN DEPENDENT DIABETES MELLITUS; PHENOTYPE; PRIORITY JOURNAL; REVIEW;

EID: 0030846278     PISSN: 09232494     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0923-2494(97)87236-7     Document Type: Article

References (31)

1. Barnett, A.H., Eff, C., Leslie, R.D.G. & Pyke, D.A. (1981), Diabetes in Identical twins. A study of 200 pairs. Diabetologia, 20, 87-93.
2. Bendelac, A., Carnaud, C., Boitard, C. & Bach, J.-F. (1987), Syngeneic transfer of autoimmune diabetes from diabetic NOD mice to healthy neonates : requirement for both L3T4+ and Ly+2+ T cells. J. Exp. Med., 166, 823-832.
3. Birk, O.S., Douek, D.C., Elias, D., Takacs, K., Dewchand, H., Gur, S.L., Walker, M.D., van der Zee, R., Cohen, I.R. & Altmann, D.M. (1996), The role of hsp60 in autoimmune diabetes : analysis in a transgenic model. Proc. Natl. Acad. Sci. USA, 93, 1032-1037.
4. Bowman, M.A., Leiter, E.H. & Atkinson, M.A. (1994), Prevention of diabetes in NOD mice : implications for therapeutic intervention in human disease. Immunol. Today, 15, 115-120.
5. g7 molecules from non-obese diabetic mice are poor peptide binders. J. Immunol., 24, 313-319.
6. Cohen, I.R. (1992), The cognitive paradigm and the immunological homunculus. Immunol. Today, 13, 490-494.
7. Cohen, I.R. (1995a), The life and times of T cell vaccination in "T cell vaccination and autoimmune disease" (J. Zhang & J. Raus) (pp.7-17). R.G. Landes Company, Texas.
8. Cohen, I.R. (1995b), Treatment of autoimmune disease: to activate or to deactivate? Chem. Immunol., 60, 150-160.
9. Cohen, I.R. (1997), The Th1/Th2 dichotomy, hsp60 autoimmunity and type I diabetes. Clin. Immunol. Immunopathol., in press.
10. Elias, D. (1994), The NOD mouse: a model for autoimmune insulin-dependent diabetes, in "Autoimmune Disease Models - A Guidebook" (I.R. Cohen & A. Miller) (pp. 147-161), Academic Press, San Diego, CA.
11. Elias, D. & Cohen, I.R. (1995), Treatment of autoimmune diabetes in NOD mice. Diabetes, 44, 1132-1138.
12. Elias, D. & Cohen, I.R. (1996), The hsp60 peptide p277 arrests the autoimmune diabetes induced by the toxin streptozotocin. Diabetes, 45, 1158-1172.
13. Elias, D., Markovits, D., Reshef, T., van der Zee, R. & Cohen, I.R. (1990), Induction and therapy of autoimmune diabetes in the non-obese diabetic (NOD/Lt) mouse by a 65-kDa heat shock protein. Proc. Natl. Acad. Sci. USA, 87, 1576-1580.
14. Elias, D., Reshef, T., Birk, O.S., van der Zee, R., Walker, M.D. & Cohen, I.R. (1991), Vaccination against autoimmune mouse diabetes with a T-cell epitope of the human 65-kDa heat shock protein. Proc. Natl., Acad. Sci. USA, 88, 3088-3091.
15. Elias, D., Prigozin, H., Polak, N., Rapoport, M., Lohse, A.W. & Cohen, I.R. (1994), Autoimmune diabetes induced by the β-cell toxin STZ. Diabetes, 43, 992-998.
16. Elias, D., Marcus, H., Reshef, T., Ablamunits, V. & Cohen, I.R. (1995), Induction of diabetes in standard mice by immunization to the p277 peptide of a 60kDa heat shock protein. Eur. J. Immunol., 25, 2851-2857.
17. Elias, D., Meilin, A., Ablamunits, V., Birk, O.S., Carmi, P., Könen-Waisman, S. & Cohen, I.R. (1997), Hsp60 peptide therapy of NOD mouse diabetes induces a Th2 cytokine burst and down-regulates autoimmunity to various β-cell antigens. Diabetes (in press).
18. g7, the class II major histocompatibility complex (MHC) molecule of NOD and Biozzi AB/H mice. J. Exp. Med., 185, 1013-1021.
19. Katz, J.D., Benoist, C. & Mathis, D. (1995), T helper cell subsets in insulin-dependent diabetes. Science, 265, 1185-1188.
20. Kwok, W.W., Domeier, M.E., Raymond, F.C., Byers, P. & Nepom, G.T. (1996), Allele-specific motifs characterize HLA-DQ interactions with a diabetes-associated peptide derived from glutamic acid decarboxylase. J. Immunol., 156, 2171-2177.
21. Liblau, R.S., Singer, S.M. & McDevitt, H.Q. (1995), Th1 and Th2 CD4+ T cells in the pathogenesis of organspecific autoimmune diseases. Immunol. Today, 16, 34-38.
22. Reizis, B., Eisenstein, M., Bockova, J., Könen-Waisman, S., Mor, F., Elias, D. & Cohen, I.R. (1997a), Molecular characterization of the diabetes-associated mouse MHC class II protein, I-Ag7. Int. Immunol., 9, 43-51.
23. Reizis, B., Altmann, D.M. & Cohen, I.R. (1997b), SDS-instability of HLA-DQ peptide complexes is associated with genetic susceptibility to type I diabetes. Eur. J. Immunol., in press.
24. Roep, B.O. (1996), T-cell responses to autoantigens in IDDM. The search for the holy grail. Diabetes, 45, 1147-1156.
25. Tian, J., Atkinson, M.A., Clare-Salzler, M., Herschenfeld, A., Forsthuber, T., Lehmann, P.V. & Kaufmann, D.L. (1996), Nasal administration of glutamate decarboxylase (GAD65) peptides induces Th2 responses and prevents murine insulin-dependent diabetes. J. Exp. Med., 183, 1561-1567.
26. Tisch, R. & McDevitt, H.Q. (1996), Insulin-dependent diabetes mellitus. Cell, 85, 291-297.
27. Vyse, T.J. & Todd, J.A. (1996), Genetic analysis of autoimmune disease. Cell, 85, 311-318.
28. Wegmann, D.R., Norbury-Glaser, M. & Daniel D. (1994), Insulin-specific T cells are a predominant component of islet infiltrates in pre-diabetic NOD mice. Eur. J. Immunol., 24, 1853-1857.
29. Wicker, L.S., Todd, J.A., & Peterson, L.B. (1995), Genetic control of autoimmune diabetes in the NOD mouse. Annu. Rev. Immunol., 13, 179-200.
30. Wogensen, L. , Lee, M.S. & Sarvetnick, N. (1994), Production of interleukin 10 by islet cells accelerates immune mediated destruction of beta cells in non-obese diabetic mice. J. Exp. Med., 179, 1379-1384.
31. Zhang, Z.J., Davidson, L., Eisenbarth, G.S. & Weiner, H.L. (1991), Suppression of diabetes in non-obese diabetic mice by oral administration of porcine insulin. Proc. Natl. Acad. Sci. USA, 88, 10252-10256.